Xie Y - Search Results

1

Long-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study.

Yuan Y, Wang Q, Ni Z, Che X, Cao L, Shao X, Zhang M, Xie Y, Qi C, Zhou W, Tian L, Mou S. Yuan Y, et al. Among authors: xie y. J Transl Med. 2015 Jun 6;13:186. doi: 10.1186/s12967-015-0549-2. J Transl Med. 2015. PMID: 26048044 Free PMC article.

2

Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.

Xue W, Xie Y, Wang Q, Xu W, Mou S, Ni Z. Xue W, et al. Among authors: xie y. Nephrology (Carlton). 2014 Apr;19(4):186-94. doi: 10.1111/nep.12173. Nephrology (Carlton). 2014. PMID: 24165570

3

Urinary excretion of liver-type FABP as a new clinical marker for the progression of obstructive nephropathy.

Xie Y, Xu W, Wang Q, Shao X, Ni Z, Mou S. Xie Y, et al. Biomark Med. 2014;8(4):543-56. doi: 10.2217/bmm.13.136. Biomark Med. 2014. PMID: 24796620

4

Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission.

Ni Z, Yuan Y, Wang Q, Cao L, Che X, Zhang M, Xie Y, Qi C, Mou S. Ni Z, et al. Among authors: xie y. J Transl Med. 2014 Jul 10;12:194. doi: 10.1186/1479-5876-12-194. J Transl Med. 2014. PMID: 25011573 Free PMC article.

5

Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes.

Xie Y, Xue W, Shao X, Che X, Xu W, Ni Z, Mou S. Xie Y, et al. PLoS One. 2014 Nov 17;9(11):e112865. doi: 10.1371/journal.pone.0112865. eCollection 2014. PLoS One. 2014. PMID: 25402279 Free PMC article.

6

Blood HCO3- concentration predicts the long-term prognosis of acute kidney injury patients.

Che X, Xie Y, Wang C, Wang Q, Zhang M, Qi C, Ni Z, Mou S. Che X, et al. Among authors: xie y. Biomark Med. 2014;8(10):1219-26. doi: 10.2217/bmm.14.91. Biomark Med. 2014. PMID: 25525982

7

L-FABP: A novel biomarker of kidney disease.

Xu Y, Xie Y, Shao X, Ni Z, Mou S. Xu Y, et al. Among authors: xie y. Clin Chim Acta. 2015 May 20;445:85-90. doi: 10.1016/j.cca.2015.03.017. Epub 2015 Mar 20. Clin Chim Acta. 2015. PMID: 25797895 Review.

8

The long-term efficacy and safety of immunosuppressive therapy on the progression of IgA nephropathy: a meta-analysis of controlled clinical trials with more than 5-year follow-up.

Tian L, Shao X, Xie Y, Wang L, Wang Q, Che X, Ni Z, Mou S. Tian L, et al. Among authors: xie y. Expert Opin Pharmacother. 2015 Jun;16(8):1137-47. doi: 10.1517/14656566.2015.1038238. Epub 2015 Apr 20. Expert Opin Pharmacother. 2015. PMID: 25892092

9

Astragaloside IV suppresses transforming growth factor-β1 induced fibrosis of cultured mouse renal fibroblasts via inhibition of the MAPK and NF-κB signaling pathways.

Che X, Wang Q, Xie Y, Xu W, Shao X, Mou S, Ni Z. Che X, et al. Among authors: xie y. Biochem Biophys Res Commun. 2015 Sep 4;464(4):1260-1266. doi: 10.1016/j.bbrc.2015.07.116. Epub 2015 Jul 26. Biochem Biophys Res Commun. 2015. PMID: 26220342

10

Association of Relapse with Renal Outcomes under the Current Therapy Regimen for IgA Nephropathy: A Multi-Center Study.

Yuan Y, Che X, Ni Z, Zhong Y, Qi Y, Shao X, Wang Q, Cao L, Zhang M, Xie Y, Qi C, Tian L, Mou S. Yuan Y, et al. Among authors: xie y. PLoS One. 2015 Sep 15;10(9):e0137870. doi: 10.1371/journal.pone.0137870. eCollection 2015. PLoS One. 2015. PMID: 26371477 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,462 results

Search Page

Filters